Cat. No.: DCL-001181
Product Information | |
---|---|
Organism | Human (Diseased) |
Tissue | Human adipose tissue |
Cell Type | Adipose-derived stem cells |
Product Description | Human Adipose-Derived Stem cells (ADSCs) are isolated from human lipoaspirate tissue collected during elective surgical liposuction procedures. ADSCs are available for normal donors, patients with Type 1 Diabetes, Type 2 Diabetes, or Obesity (BMI>30). It has been shown that the ADSCs demonstrate very similar phenotypic and functional characteristics to that of bone marrow-derived mesenchymal stem cells. Thousands of articles have been published on ADSCs using a variety of terminology, including preadipocytes, adipose-derived mesenchymal stem cells (AD-MSCs), adipose MSCs (AMSCs), adipose-derived adult stem (ADAS) cells, and adipose stromal/stem cells (ASCs). Normal human ADSCs have been reported to differentiate into many different lineages including chondrogenic, osteogenic, adipogenic and neural. And have been applied in studies include stem cell differentiation, regenerative medicine , and cell therapy . offers normal human adipose-derived stem cells (hADSC) from adipose tissues from single donor, and cryopreserved at passage 1. hADSC are positive for CD29, CD44, CD73, CD90, CD105, and negative for CD14, CD31, CD45. hADSC can be in vitro differentiated into adipocytes and osteoblasts using Adipocyte Differentiation Medium (Cat # MD-0005) and Osteogenic Differentiation Medium (Cat # MD-0006), separately. hADSC can be further expanded for 3-4 passages using Adipose-Derived Stem Cell Growth Medium (Cat# MD-0003). These cells are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast, and fungi. |
Gene Description | Human adipose tissue from liposuction procedures |
Format | Frozen |
Growth Properties | Adherent |
Shipping & Storage | |
---|---|
Shipping | Cryopreserved on dry ice. |
Storage Instructions | 37 °C, 95% Air, 5% CO2. Store in vapor phase of liquid nitrogen. |
Storage Buffer/Media | Adipose-Derived Stem Cell Growth Medium Adipocyte Differentiation Medium Osteogenic Differentiation Medium |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.